# Cromoglicate in Mastocytosis

> **NCT01701843** · PHASE2 · TERMINATED · sponsor: **LEO Pharma** · enrollment: 7 (actual)

## Conditions studied

- Mastocytosis

## Interventions

- **DRUG:** Cromoglicate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01701843
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** prematurely terminated because of low recruitment
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01701843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01701843, "Cromoglicate in Mastocytosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01701843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*